Cargando…

Hypokalemia with Trifluoperazine at Therapeutic Dose

This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehman, Sajjadur, Chetia, Dhruba Jyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461850/
https://www.ncbi.nlm.nih.gov/pubmed/28615774
http://dx.doi.org/10.4103/0253-7176.207315
_version_ 1783242414821998592
author Rehman, Sajjadur
Chetia, Dhruba Jyoti
author_facet Rehman, Sajjadur
Chetia, Dhruba Jyoti
author_sort Rehman, Sajjadur
collection PubMed
description This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the same effect at a milder level. No cardiac abnormalities were detected with the presentation. Naranjo adverse drug reaction probability scale reported definite relation with the drug.
format Online
Article
Text
id pubmed-5461850
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54618502017-06-14 Hypokalemia with Trifluoperazine at Therapeutic Dose Rehman, Sajjadur Chetia, Dhruba Jyoti Indian J Psychol Med Case Report This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the same effect at a milder level. No cardiac abnormalities were detected with the presentation. Naranjo adverse drug reaction probability scale reported definite relation with the drug. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5461850/ /pubmed/28615774 http://dx.doi.org/10.4103/0253-7176.207315 Text en Copyright: © 2017 Indian Psychiatric Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Rehman, Sajjadur
Chetia, Dhruba Jyoti
Hypokalemia with Trifluoperazine at Therapeutic Dose
title Hypokalemia with Trifluoperazine at Therapeutic Dose
title_full Hypokalemia with Trifluoperazine at Therapeutic Dose
title_fullStr Hypokalemia with Trifluoperazine at Therapeutic Dose
title_full_unstemmed Hypokalemia with Trifluoperazine at Therapeutic Dose
title_short Hypokalemia with Trifluoperazine at Therapeutic Dose
title_sort hypokalemia with trifluoperazine at therapeutic dose
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461850/
https://www.ncbi.nlm.nih.gov/pubmed/28615774
http://dx.doi.org/10.4103/0253-7176.207315
work_keys_str_mv AT rehmansajjadur hypokalemiawithtrifluoperazineattherapeuticdose
AT chetiadhrubajyoti hypokalemiawithtrifluoperazineattherapeuticdose